Cargando…

Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database

BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnost...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Guangzhao, Zhi, Yao, Fan, Zhongqi, Qiu, Wei, Lv, Guoyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394832/
https://www.ncbi.nlm.nih.gov/pubmed/37538313
http://dx.doi.org/10.3389/fmed.2023.1171023
_version_ 1785083457257340928
author Shao, Guangzhao
Zhi, Yao
Fan, Zhongqi
Qiu, Wei
Lv, Guoyue
author_facet Shao, Guangzhao
Zhi, Yao
Fan, Zhongqi
Qiu, Wei
Lv, Guoyue
author_sort Shao, Guangzhao
collection PubMed
description BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnostic and prognostic nomograms specifically tailored for LM in HCC patients. METHODS: A retrospective analysis was conducted on HCC patients from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2015. The study employed multivariate logistic regression analysis to identify risk factors associated with LM in HCC patients. Additionally, multivariate Cox proportional hazards regression analysis was utilized to investigate prognostic factors for HCC patients with LM. Subsequently, two nomograms were developed to predict the risk and prognosis of LM in HCC patients. The performance of the nomograms was evaluated through calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULT: This retrospective study included a total of 5,934 patients diagnosed with HCC, out of which 174 patients were diagnosed with LM. Through multivariate logistic regression analysis, several independent risk factors for LM in HCC patients were identified, including tumor grade, tumor size, American Joint Committee for Cancer (AJCC) T stage, and AJCC N stage. Furthermore, multivariate Cox analysis revealed that tumor grade, delayed treatment, surgery, and radiation were independent prognostic factors for HCC patients with LM. To assess the predictive power of the developed nomograms, calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) were employed. The findings demonstrated that the nomograms exhibited satisfactory performance in both the training and validation sets. Additionally, the prognostic nomogram effectively stratified HCC patients with LM into low- and high-risk groups for mortality. CONCLUSION: These two nomograms optimally predicted the risk and prognosis of LM in HCC patients. Both nomograms have satisfactory performance. This would help clinicians to make accurate clinical decisions.
format Online
Article
Text
id pubmed-10394832
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103948322023-08-03 Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database Shao, Guangzhao Zhi, Yao Fan, Zhongqi Qiu, Wei Lv, Guoyue Front Med (Lausanne) Medicine BACKGROUND: Lung metastasis (LM) is a common occurrence in patients with hepatocellular carcinoma (HCC), and it is associated with a poorer prognosis compared to HCC patients without LM. This study aimed to identify predictors and prognostic factors for LM in HCC patients as well as develop diagnostic and prognostic nomograms specifically tailored for LM in HCC patients. METHODS: A retrospective analysis was conducted on HCC patients from the Surveillance, Epidemiology, and End Results (SEER) database, covering the period from 2010 to 2015. The study employed multivariate logistic regression analysis to identify risk factors associated with LM in HCC patients. Additionally, multivariate Cox proportional hazards regression analysis was utilized to investigate prognostic factors for HCC patients with LM. Subsequently, two nomograms were developed to predict the risk and prognosis of LM in HCC patients. The performance of the nomograms was evaluated through calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). RESULT: This retrospective study included a total of 5,934 patients diagnosed with HCC, out of which 174 patients were diagnosed with LM. Through multivariate logistic regression analysis, several independent risk factors for LM in HCC patients were identified, including tumor grade, tumor size, American Joint Committee for Cancer (AJCC) T stage, and AJCC N stage. Furthermore, multivariate Cox analysis revealed that tumor grade, delayed treatment, surgery, and radiation were independent prognostic factors for HCC patients with LM. To assess the predictive power of the developed nomograms, calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA) were employed. The findings demonstrated that the nomograms exhibited satisfactory performance in both the training and validation sets. Additionally, the prognostic nomogram effectively stratified HCC patients with LM into low- and high-risk groups for mortality. CONCLUSION: These two nomograms optimally predicted the risk and prognosis of LM in HCC patients. Both nomograms have satisfactory performance. This would help clinicians to make accurate clinical decisions. Frontiers Media S.A. 2023-07-19 /pmc/articles/PMC10394832/ /pubmed/37538313 http://dx.doi.org/10.3389/fmed.2023.1171023 Text en Copyright © 2023 Shao, Zhi, Fan, Qiu and Lv. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Shao, Guangzhao
Zhi, Yao
Fan, Zhongqi
Qiu, Wei
Lv, Guoyue
Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title_full Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title_fullStr Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title_full_unstemmed Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title_short Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database
title_sort development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the seer database
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394832/
https://www.ncbi.nlm.nih.gov/pubmed/37538313
http://dx.doi.org/10.3389/fmed.2023.1171023
work_keys_str_mv AT shaoguangzhao developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase
AT zhiyao developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase
AT fanzhongqi developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase
AT qiuwei developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase
AT lvguoyue developmentandvalidationofadiagnosticandprognosticmodelforlungmetastasisofhepatocellularcarcinomaastudybasedontheseerdatabase